Stock Events

Stock Events

Convergenze SPA 

€1.69
38
-€0.01-0.59% Today

Statistics

Day High
1.69
Day Low
1.69
52W High
2.16
52W Low
1.61
Volume
-
Avg. Volume
-
Mkt Cap
19.47B
P/E Ratio
23.86
Dividend Yield
1.18%
Dividend
0.02

Upcoming

2
JUN
Dividend Ex
Estimated
 
4
JUN
Dividend Payment
Estimated
 
2
JUN 27
Dividend Ex
Estimated
 
4
JUN 27
Dividend Payment
Estimated
 
2
JUN 28
Dividend Ex
Estimated
 

Dividends

1.18%Dividend Yield
Jun 25
€0.02
May 24
€0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

25MarExpected
Q4 2023
Q2 2024
Q1 2025
Q2 2025
Q4 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

14.89%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
7.62BRevenue
1.13BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 7E0.F. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Roche
RHHBY
Mkt Cap330.22B
Roche Holding AG is a major player in the pharmaceutical industry, directly competing with CSPC in various therapeutic areas, including oncology and immunology.
Pfizer
PFE
Mkt Cap156.77B
Pfizer Inc. competes globally in the pharmaceutical sector, offering a wide range of products that overlap with CSPC's portfolio, especially in the development of innovative drugs and vaccines.
Novartis
NVS
Mkt Cap293.34B
Novartis AG is a global healthcare company that competes with CSPC Pharmaceutical in areas such as research, development, manufacturing, and marketing of pharmaceuticals.
Merck
MRK
Mkt Cap294.39B
Merck & Co., Inc. is a leading pharmaceutical company that competes with CSPC in developing and marketing drugs in various therapeutic areas, including cancer and infectious diseases.
GSK
GSK
Mkt Cap117.55B
GlaxoSmithKline plc is a global healthcare company that competes with CSPC in the pharmaceutical and healthcare sector, particularly in the development of vaccines and medications.
Abbvie
ABBV
Mkt Cap368.57B
AbbVie Inc. competes with CSPC in the biopharmaceutical field, focusing on developing drugs for conditions such as autoimmune diseases and cancer.
Sanofi
SNY
Mkt Cap115.14B
Sanofi competes with CSPC in the global pharmaceutical market, focusing on areas such as diabetes solutions, human vaccines, and innovative drugs.
Bristol-Myers Squibb
BMY
Mkt Cap122.85B
Bristol-Myers Squibb Company is a global biopharmaceutical company competing with CSPC in the discovery, development, and delivery of medicines in areas like cancer and cardiovascular diseases.
Astrazeneca
AZN
Mkt Cap317.5B
AstraZeneca PLC is a multinational pharmaceutical and biopharmaceutical company that competes with CSPC in developing and commercializing prescription medicines for several major disease areas.
Johnson & Johnson
JNJ
Mkt Cap564.35B
Johnson & Johnson is a diversified healthcare giant that competes with CSPC Pharmaceutical across a broad range of therapeutic areas and products, including pharmaceuticals and biotechnology.

About

Convergenze S.p.A. Società Benefit provides Internet services, voice, energy, and natural gas services. The company offers fiber optic network and WiFi; fixed telephony services; and value-added services such as cloud services, datacenter, and virtualization services. It also provides electricity supply service for the households and business customers; charging points for electric cars; and natural gas supply services. Convergenze S.p.A. Società Benefit was founded in 2005 and is headquartered in Salerno, Italy.
Show more...
CEO
Engineer Rosario Pingaro
Employees
104
Country
Italy
ISIN
IT0005426215
WKN
000A2QLMP

Listings

MX
MX
1093N.MX
STU
DE
CVG.STU
MU
DE
CVG.MU
F
DE
CVG.F

0 Comments

Share your thoughts

FAQ

What is Convergenze SPA stock price today?▼
The current price of 7E0.F is €1.69 EUR — it has decreased by -0.59% in the past 24 hours. Watch Convergenze SPA stock price performance more closely on the chart.
What is Convergenze SPA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Convergenze SPA stocks are traded under the ticker 7E0.F.
Is Convergenze SPA stock price growing?▼
7E0.F stock has risen by +0% compared to the previous week, the month change is a +1.2% rise, over the last year Convergenze SPA has showed a +0.6% increase.
What is Convergenze SPA market cap?▼
Today Convergenze SPA has the market capitalization of 19.47B
When is the next Convergenze SPA earnings date?▼
Convergenze SPA is going to release the next earnings report on August 26, 2026.
What is Convergenze SPA revenue for the last year?▼
Convergenze SPA revenue for the last year amounts to 7.62B EUR.
What is Convergenze SPA net income for the last year?▼
7E0.F net income for the last year is 1.13B EUR.
Does Convergenze SPA pay dividends?▼
Yes, 7E0.F dividends are paid annual. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (FWD)% is 1.18%.
How many employees does Convergenze SPA have?▼
As of April 22, 2026, the company has 104 employees.
In which sector is Convergenze SPA located?▼
Convergenze SPA operates in the Communication sector.
When did Convergenze SPA complete a stock split?▼
The last stock split for Convergenze SPA was on October 15, 2020 with a ratio of 8:5.
Where is Convergenze SPA headquartered?▼
Convergenze SPA is headquartered in Salerno, Italy.